As advocates for patient rights and healthcare justice, we at AWKO Law Firm are deeply concerned by the recent ProPublica and Capitol Forum investigation into EviCore by Evernorth, a subsidiary of Cigna. This investigation has revealed a disturbing trend in the health insurance industry that threatens patient care and undermines the integrity of our healthcare system.
The AI-Driven Denial Machine
At the heart of this controversy is EviCore’s use of an artificial intelligence algorithm, colloquially known as “the dial.” This sophisticated tool, far from being a neutral arbiter of medical necessity, appears to be a finely tuned instrument for maximizing profits at the expense of patient care.
How “The Dial” Works
The investigation reveals that EviCore’s algorithm operates as the first line of evaluation for prior authorization requests. While it can automatically approve requests, it cannot issue denials. Instead, when the algorithm flags potential issues, it routes the request to EviCore’s in-house medical team for review.
The truly concerning aspect is the company’s ability to adjust this algorithm to increase the number of requests sent for human review. Former employees disclosed that the algorithm assigns scores to requests based on their likelihood of approval. EviCore can then set thresholds for which scores trigger a review, effectively controlling the denial rate.
The Profit Motive Behind Denials
EviCore’s business model is built on a promise to insurance companies: a 3-to-1 return on investment. In other words, for every dollar an insurer spends on EviCore’s services, they expect to save three dollars on medical care and related costs. This creates a perverse incentive structure where denying care becomes a path to profitability.
The investigation uncovered that EviCore salespeople have boasted of achieving a 15% increase in denials. In Arkansas, where denial rates must be published, EviCore has turned down prior authorization requests, either fully or partially, nearly 20% of the time since 2021. This rate is alarmingly high compared to the 7% denial rate for federal Medicare Advantage plans in 2022.
Legal and Ethical Implications
As legal professionals, we at AWKO find several aspects of this situation deeply troubling:
- Potential Violation of Fiduciary Duty: Insurance companies have a fiduciary duty to act in the best interests of their policyholders. The use of a system designed to increase denials potentially violates this duty.
- Informed Consent Issues: Patients are likely unaware that their care decisions are being influenced by an AI system optimized for cost-cutting rather than medical necessity.
- Medical Malpractice Concerns: When legitimate medical recommendations are overridden by an AI system, it raises questions about liability in cases where denied care leads to adverse health outcomes.
- Regulatory Compliance: The opaque nature of the AI decision-making process may run afoul of insurance regulations requiring transparency and fairness in claims processing.
The Human Cost
Behind every denied claim is a patient in need of care. The investigation highlights cases where EviCore’s denials have had serious consequences for patients’ health. As Barbara McAneny, a former president of the American Medical Association and practicing oncologist, starkly puts it, these companies approve prior authorizations “based on the decision that is more profitable for them. They love to deny things.”
The Need for Accountability and Reform
The revelations about EviCore’s practices highlight the urgent need for greater oversight and regulation in the health insurance industry. As a law firm committed to protecting the rights of individuals, we believe that several steps must be taken:
- Thorough Investigation: Regulatory bodies must conduct a comprehensive investigation into EviCore’s practices and the use of AI in claim processing across the industry.
- Transparency Requirements: Insurance companies should be required to disclose their use of AI in claim processing and provide clear explanations for claim denials.
- Enhanced Oversight: There should be increased regulatory oversight of AI systems used in healthcare decision-making.
- Patient Advocacy: We need stronger mechanisms for patients to appeal claim denials and seek independent medical reviews.
- Legal Action: Where appropriate, legal action should be taken to hold insurance companies accountable for unfair or illegal practices.
The Role of Legal Advocacy
At AWKO, we believe that legal advocacy plays a crucial role in addressing these issues. Attorneys can:
- Represent patients who have been wrongfully denied coverage.
- File class-action lawsuits against insurance companies engaged in unfair practices.
- Advocate for legislative changes to strengthen patient protections.
- Work with regulatory bodies to enhance oversight of the insurance industry.
Looking Forward
The EviCore controversy serves as a stark reminder of the ongoing challenges in our healthcare system. As we move forward, it is crucial that we strike a balance between technological innovation and patient care. AI can be a powerful tool in healthcare, but it must be implemented with robust ethical guidelines and human oversight.
As legal professionals, we at AWKO are committed to fighting for the rights of patients and holding insurance companies accountable for their actions. We believe that through diligent legal work, advocacy, and a commitment to justice, we can help create a healthcare system that truly puts patients first.
In conclusion, the allegations against EviCore and Cigna are deeply troubling and demand immediate attention. As a society, we must ensure that our healthcare system prioritizes patient care over profit, and that the promise of technological advancement does not come at the cost of fairness and compassion. At AWKO, we stand ready to take on this challenge and fight for the rights of patients across the nation.